BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS
Bio-Techne (NASDAQ: TECH) has announced a conference call and webcast scheduled for October 30, 2024, at 8:00 a.m. CDT to discuss its first quarter fiscal 2025 financial results. Interested parties can access the call via phone or webcast. The dial-in numbers are 1-877-407-9208 for domestic callers and 1-201-493-6784 for international callers, with the Conference ID 13749405. A webcast link is also provided.
For those unable to join the live call, a recorded rebroadcast will be available from 11:00 a.m. CDT on October 30, 2024, until 11:00 p.m. CST on November 30, 2024. The replay can be accessed by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and using the same Conference ID.
Bio-Techne (NASDAQ: TECH) ha annunciato una conference call e una trasmissione in diretta programmata per 30 ottobre 2024, alle 8:00 CDT per discutere i suoi risultati finanziari del primo trimestre dell'esercizio 2025. Le parti interessate possono partecipare alla chiamata tramite telefono o webcast. I numeri per accedere sono 1-877-407-9208 per i chiamanti nazionali e 1-201-493-6784 per i chiamanti internazionali, con ID Conferenza 13749405. È anche fornito un link per la trasmissione.
Per coloro che non possono partecipare alla chiamata in diretta, una registrazione sarà disponibile da 11:00 CDT del 30 ottobre 2024, fino alle 23:00 CST del 30 novembre 2024. La registrazione può essere ascoltata componendo 1-844-512-2921 (nazionale) o 1-412-317-6671 (internazionale) utilizzando lo stesso ID Conferenza.
Bio-Techne (NASDAQ: TECH) ha anunciado una conferencia telefónica y webcast programados para 30 de octubre de 2024, a las 8:00 a.m. CDT para discutir sus resultados financieros del primer trimestre del año fiscal 2025. Las partes interesadas pueden acceder a la llamada por teléfono o webcast. Los números de acceso son 1-877-407-9208 para llamadas nacionales y 1-201-493-6784 para llamadas internacionales, con ID de Conferencia 13749405. También se proporciona un enlace para la transmisión.
Para aquellos que no puedan unirse a la llamada en vivo, una grabación estará disponible desde 11:00 a.m. CDT del 30 de octubre de 2024, hasta las 11:00 p.m. CST del 30 de noviembre de 2024. La repetición se puede acceder marcando 1-844-512-2921 (nacional) o 1-412-317-6671 (internacional) y utilizando el mismo ID de Conferencia.
Bio-Techne (NASDAQ: TECH)는 2024년 10월 30일 오전 8:00 CDT에 첫 분기 재무 결과를 논의하기 위한 컨퍼런스 콜 및 웹캐스트를 예정했다고 발표했습니다. 관심 있는 분들은 전화 또는 웹캐스트를 통해 통화에 참여할 수 있습니다. 국내 호출자는 1-877-407-9208, 국제 호출자는 1-201-493-6784로 연락할 수 있으며, 회의 ID는 13749405입니다. 웹캐스트 링크도 제공됩니다.
실시간 통화에 참여할 수 없는 분들을 위해 2024년 10월 30일 오전 11:00 CDT부터 2024년 11월 30일 오후 11:00 CST까지 녹화된 재방송이 제공됩니다. 재방송은 1-844-512-2921 (국내) 또는 1-412-317-6671 (국제)로 전화하여 동일한 회의 ID를 사용하여 접근할 수 있습니다.
Bio-Techne (NASDAQ: TECH) a annoncé une conférence téléphonique et un webinaire prévus pour le 30 octobre 2024 à 8h00 CDT pour discuter de ses résultats financiers du premier trimestre de l'exercice 2025. Les parties intéressées peuvent accéder à l'appel par téléphone ou par webinaire. Les numéros pour se connecter sont 1-877-407-9208 pour les appelants nationaux et 1-201-493-6784 pour les appelants internationaux, avec l'ID de conférence 13749405. Un lien de webdiffusion est également fourni.
Pour ceux qui ne peuvent pas participer à l'appel en direct, un enregistrement sera disponible à partir de 11h00 CDT le 30 octobre 2024 jusqu'à 23h00 CST le 30 novembre 2024. La rediffusion peut être obtenue en composant le 1-844-512-2921 (national) ou le 1-412-317-6671 (international) et en utilisant le même ID de conférence.
Bio-Techne (NASDAQ: TECH) hat eine Telefonkonferenz und ein Webcast für 30. Oktober 2024 um 8:00 Uhr CDT angekündigt, um über die Finanzergebnisse des ersten Quartals 2025 zu berichten. Interessierte Parteien können an dem Anruf per Telefon oder Webcast teilnehmen. Die Telefonnummern sind 1-877-407-9208 für nationale Anrufer und 1-201-493-6784 für internationale Anrufer, mit der Konferenz-ID 13749405. Ein Webcast-Link wird ebenfalls bereitgestellt.
Für diejenigen, die nicht an der Live-Anruf teilnehmen können, wird eine aufgezeichnete Wiederholung von 11:00 Uhr CDT am 30. Oktober 2024 bis 23:00 Uhr CST am 30. November 2024 verfügbar sein. Die Wiederholung kann unter der Nummer 1-844-512-2921 (national) oder 1-412-317-6671 (international) unter Verwendung derselben Konferenz-ID abgerufen werden.
- None.
- None.
Access to the discussion may be obtained as follows:
Time: | 8:00 a.m. CDT |
Date: | October 30, 2024 |
Dial-in: | 1-877-407-9208 or 1-201-493-6784 (for international callers) |
Conference ID: | 13749405 |
Webcast: |
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 13749405.
The replay will be available from 11:00 a.m. CDT on Wednesday, October 30, 2024, until 11:00 p.m. CST on Saturday, November 30, 2024.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Contact: | David Clair, Vice President, Investor Relations & Corporate Development |
612-656-4416 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-october-30-2024-to-announce-first-quarter-fiscal-2025-financial-results-302271430.html
SOURCE Bio-Techne Corporation
FAQ
When will Bio-Techne (TECH) report its Q1 2025 financial results?
How can investors access Bio-Techne's (TECH) Q1 2025 earnings call?
Will there be a replay available for Bio-Techne's (TECH) Q1 2025 earnings call?
